论文部分内容阅读
复方丹参片(丹参浸膏215克、三七141克、冰片8克)为《药典》方,1977年上海中药制药二厂率先研制成功并批号生产,同时广泛应用于临床各科,并取得了满意的疗效。近些年来,临床使用范围正逐渐扩大,尤其对患有高血压、冠心病血稠的病人和肺A高压缺氧的患者,改善临床症状有显著效果。鉴于本方应用范围的扩大,以及进一步提高药效的作用,广大药学工作者对本方进行了新的剂型改造和研究,现综述如下。复方丹参注射液按四川省药品标准收载复方
Compound Danshen Tablets (215 grams of Danshen extract, 437 grams of Panax notoginseng, and 8 grams of borneol) are the “Pharmacopoeia” parties. In 1977, the Shanghai No. 2 Pharmaceutical Factory of Traditional Chinese Medicine was successfully developed and batch-produced. At the same time, it was widely used in various clinical departments and achieved Satisfactory efficacy. In recent years, the scope of clinical use is gradually expanding, especially for patients with high blood pressure, coronary heart disease with thick blood, and patients with pulmonary hypertension and hypoxia. There are significant results in improving clinical symptoms. In view of the expansion of the scope of application of this party, as well as the further improvement of the efficacy of pharmaceuticals, the majority of pharmaceutical workers have conducted new formulations and research on this side, which are summarized below. Compound Salvia miltiorrhiza injection is compounded according to Sichuan drug standards